Κυριακή 29 Νοεμβρίου 2020

Hepatitis A antibody persistence 8 and 10  years after 1-dose and 2-dose vaccination in children from Panama.

alkiviadis.1961 shared this article with you from Inoreader

Message:

...

Via Vaccine

fbworm.png

CONCLUSION: Anti-HAV antibody persistence was observed in lower percentages of children receiving 1 dose versus 2 doses of Havrix, at 8 and 10 years post-vaccination in Panama. Further investigations are needed to confirm antibody persistence and conclude on the protection afforded beyond 10 years in the pediatric population in Latin America. PMID: 33239226 [PubMed - as supplied by publisher] (Source: Vaccine)
View on the web

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.